NDC 0781-3101-80 - Oxacillin
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 0781-3101
- Requested NDC
- 0781-3101-80
- Package NDCs from labels
- 0781-3101-80, 0781-3101-95
- Manufacturer
- Sandoz Inc
- Effective date
- 2015-09-30
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| Oxacillin - Sandoz Inc | Sandoz Inc | 2015-09-30 | HUMAN PRESCRIPTION DRUG LABEL |
| National Council for Prescription Drug Programs indexing - billing unit | National Council for Prescription Drug Programs | 2012-07-24 | Indexing - Billing Unit |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 0781-3101-95 | 2021-02-26 | C162847 | 48780-1 | 9d75b9d0-d1d1-f424-e053-dadaa90a57ce | Oxacillin for Injection, USP |
| 0781-3101-95 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-d1d1-f424-e053-dadaa90a57ce | Oxacillin for Injection, USP |
DailyMed Billing Units#
| Package NDC | Billing unit | Product NDC | DailyMed indexing SPL | SPL version | Effective |
|---|---|---|---|---|---|
| 0781-3101-80 | EA - Each | 0781-3101 | 0ca29655-4994-4cf8-93db-db8fe6bc7dbf | 1 | 2012-07-24 |
| 0781-3101-95 | EA - Each | 0781-3101 | 2634c288-c770-44ea-b6ac-89d0dac058ab | 1 | 2012-07-24 |
DailyMed Socrata Ingredients#
| Ingredient | Type | UNII | DailyMed label | SPL version | Uploaded |
|---|---|---|---|---|---|
| OXACILLIN SODIUM | ACTIVE INGREDIENT | G0V6C994Q5 | OXACILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 | |
| OXACILLIN | ACTIVE MOIETY | UH95VD7V76 | OXACILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 | |
| SODIUM PHOSPHATE, DIBASIC | INACTIVE INGREDIENT | GR686LBA74 | OXACILLIN INJECTION, POWDER, FOR SOLUTION [SANDOZ INC] | 14 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| OXACILLIN | OXACILLIN | Baxter Healthcare Corporation | d893e45b-7f18-4c67-b10c-1e2e52a6b3ef | 2026-08-31 | Warnings, Adverse reactions | G0V6C994Q5 |
| Para-Chord | HOMEOPATHIC LIQUID | Energetix Corporation | 9f8f646e-634a-47ff-b208-b2249d685e55 | 2026-08-11 | Warnings | GR686LBA74 |
| CVS Pharmacy | SALINE LAXATIVE | CVS Pharmacy | edd58c52-18de-4ec4-aec3-44f3e17607a7 | 2026-02-17 | Warnings | GR686LBA74 |
| Equate Ready-to-Use Enema Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | WalMart | 04c7440e-5b25-4b63-9604-321298d51021 | 2026-01-29 | Warnings | GR686LBA74 |
| Quality Choice Laxative | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Chain Drug Marketing Association | 1cac3b6b-155b-47bb-bb79-17c55d345736 | 2026-01-28 | Warnings | GR686LBA74 |
| Sunmark Saline Single Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Strategic Sourcing Services LLC | 06720229-7d58-499e-b7de-cb4bda5ae416 | 2026-01-08 | Warnings | GR686LBA74 |
| HealthMart Saline Single Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Strategic Sourcing Services LLC | 689228de-1f3e-4205-853d-6004d6248857 | 2026-01-08 | Warnings | GR686LBA74 |
| oxacillin | OXACILLIN | Onesource Specialty Pharma Limited | 4972ec74-1d9a-de9b-e063-6394a90af786 | 2025-12-31 | Warnings, Adverse reactions | G0V6C994Q5 |
| Oxacillin | OXACILLIN | Wockhardt USA LLC. | 195c2054-0746-421d-8b20-8c751bdd772b | 2025-10-24 | Warnings, Adverse reactions | G0V6C994Q5 |
| Oxacillin | OXACILLIN | Wockhardt USA LLC. | 4149d750-44e3-47e7-84f2-1e5cc839733b | 2025-10-24 | Warnings, Adverse reactions | G0V6C994Q5 |
| Oxacillin | OXACILLIN | Armas Pharmaceuticals Inc. | 8e99d6fe-42ab-44c1-8b51-e4ac7406dbe4 | 2025-09-30 | Warnings, Adverse reactions | G0V6C994Q5 |
| Leader Ready to Use Saline Laxative | SODIUM PHOSPHATE, DIBASIC AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Cardinal Health | 1b4f9c28-0547-4922-aa15-990c6fd9dc9f | 2025-09-29 | Warnings | GR686LBA74 |
| Saline Laxative | SALINE LAXATIVE | Major Pharmaceuticals | b3758ffe-1bac-4df6-9714-5e33e9d28d90 | 2025-09-16 | Warnings | GR686LBA74 |
| Oxacillin | OXACILLIN SODIUM | Eugia US LLC | 81e90279-9889-47bd-974b-334c181f295c | 2025-08-13 | Warnings, Adverse reactions | G0V6C994Q5 |
| Oxacillin | OXACILLIN SODIUM | Eugia US LLC | 152758c0-d225-4761-abeb-3f1cb0190806 | 2025-08-13 | Warnings, Adverse reactions | G0V6C994Q5 |
| Rexall Ready to use 4pk LAXATIVE | SODIUM PHOSPHATE, DIBASIC, UNSPECIFIED FORM AND SODIUM PHOSPHATE, MONOBASIC, UNSPECIFIED FORM | Dolgencorp, LLC | 78509915-0ef1-4238-99a5-78a49a68f98f | 2025-07-07 | Warnings | GR686LBA74 |
| InterSol | PLATELET ADDITIVE 3 | Fenwal, Inc. | 17dec820-1b57-4ac9-82a8-419cab664a2f | 2025-06-27 | Warnings, Adverse reactions | GR686LBA74 |
| Saline Laxative | SODIUM PHOSPHATE | Walgreen Company | fb260df0-7bda-4299-84a5-44c8f9447798 | 2025-06-18 | Warnings | GR686LBA74 |
| PRISMASOL BGK2/0 | MAGNESIUM CHLORIDE, DEXTROSE ANHYDROUS, LACTIC ACID, SODIUM CHLORIDE, SODIUM BICARBONATE, AND POTASSIUM CHLORIDE | Vantive US Healthcare LLC | 7f675fee-8940-4ece-bb0c-75ac79d8708c | 2025-05-31 | Warnings, Adverse reactions | GR686LBA74 |
| Saline Enema | SODIUM PHOSPHATE MONOBASIC, SODIUM PHOSPHATE DIBASIC | Dynarex Corporation | 7c7b68af-4ef2-4f84-9279-9f7a91c8d9c5 | 2025-05-14 | Warnings | GR686LBA74 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.